Mission
Our mission is to connect, exchange and educate.
- Connect: Bring together a broad audience including policy makers (government, regulators), funders (health foundations, charities), the academic research community (universities, research and knowledge institutes), environmental and human toxicity, industries (pharmaceutical, chemical, food, cosmetics and other industries), medical centers and practitioners, patient associations, and service/testing centers from all over the world. It will allow communication between different stakeholders as well as interaction between young scientists and senior experts in the MPS field, which will not only promote international standardization and harmonization of MPS, but also establish a global training environment.
- Exchange: Facilitate collaborative environment; learning from each other about challenges and opportunities. Implement global cooperative efforts to advance MPS development, promote this technology and accelerate acceptance by regulators and end users. This is needed to maximize its potential to advance the life sciences, from basic to clinical research, from drug screening to safety assessment.
- Educate: The mission is not only education of a new generation of scientist, but also established scientists entering the field, and regulators to allow the rapid, safe and responsible adoption of this technology.
Vision
Our vision is to accelerate the use of MPS to improve health, welfare, and the environment.
The vision is achieved through:
- Research (strengthen the society as the hub for MPS research and increase its impact)
- Education (empower current and future society members with the knowledge and resources needed in biomedical research)
- Community (cultivate a diverse, inclusive and engaged community by increasing access and opportunities for interaction)
- Increase awareness and understanding of the utility of MPS in biomedical research, its impact on health, environment and economy, and emphasize the need for funding
Core Values
- Excellence and Integrity
- Diversity, Equity and Inclusion
- Innovation and Impact
- Respect and Accountability
- Connection and Collaboration
- Education and Career Development
Bylaws
BYLAWS OF THE INTERNATIONAL MICROPHYSIOLOGICAL SYSTEMS SOCIETY
Last revised April 3, 2025
Board of Directors
President
James Hickman
Hesperos, Inc. (USA)
President-Elect
Jan Lichtenberg
InSphero (Switzerland)
Past President
Lena Smirnova
Johns Hopkins University, (USA)
Secretary
Magdalena Kasendra
Children’s Hospital of Cincinnati (USA)
Treasurer
Riccardo Barrile
University of Cincinnati (USA)
Elizabeth Baker
Dynavet Solutions (USA)
Zaozao Chen
Columbia University (USA)
Lorna Ewart
Emulate, Inc. (USA)
Suzanne Fitzpatrick
Food and Drug Administration (USA)
Chrisna Gouws
North-West University (South Africa)
Zhongze Gu
Southeast University (China)
Seiichi Ishida
NIHS (Japan)
Noo Li Jeon
Seoul National University
(South Korea)
Roger Kamm
Massachusetts Institute of Technology (USA)
Sofia Batista Leite
European Food Safety Authority (EFSA)
Peter Loskill
University of Tübingen (Germany)
Adrian Roth
Roche (Switzerland)
Michael Shuler
Cornell University (USA)
*Dan Tagle
NIH (USA)
*non-voting member
Alastair Stewart
University of Melbourne (Australia)
Evita van Steeg
TNO (Netherlands)
Joseph Wu
Stanford University (USA)